Proton Therapy Systems Market Size and Gross Margin Analysis to 2021

Global Proton Therapy Systems Market is segmented by Geographical Region into North America, Asia-Pacific, Europe, and Rest of the World. Protons are atoms that carrying positive charge. Just as X-Rays (also known as photons) are used for treating both – malignant and benign tumors, proton beams can be used for irradiating tumors Though, protons deliver a dose of radiation in a much more confined way to the tumor tissue than photons (X-Rays).  After they enter the body, protons release most of their energy within the tumor region and, unlike photons, deliver only a minimal dose beyond the tumor boundaries. Therefore, predominantly for smaller tumor sizes, the dose of radiation may reproduce much tighter to the tumor and there may be less damage to healthy tissue.

As a result, the treating physician (a radiation oncologist) can potentially give an even greater dose to the tumor while minimizing unwelcome side effects. This is especially important when treating children, because protons help reduce radiation to growing and developing tissues in the proton therapy systems market. Proton therapy delivers radiation to tumor tissue in a much more confined way than conventional photon therapy thus permitting the radiation oncologist to use a greater dose while still minimizing side effects.

If you’re programmed for proton therapy, you will likely undergo a treatment simulation session in which you will be fitted into an immobilization device to ensure you uphold the same exact position for every treatment. A CT scan will be attained to create a virtual model of your tumor, and other imaging procedures may be used to help control its exact shape and location. Your doctor will give you specific instructions based on the type of exam being performed.

As proton therapy becomes additionalextensivelyobtainable, imaging for the development of proton treatment plans will become more common. However, there are major alterations in how treatment is planned for proton therapy associated to conventional radiation therapy. Proton Therapy Systems Market is segmented by Application into Brain cancer, Head & Neck cancer, Sarcoma, Gastro-intestinal cancer, Pediatric cancer, Lung cancer, and prostate cancer.

Proton therapy applications are more inclined towards gastro-intestinal and lung cancer due to recommendations by healthcare professionals. Moreover, proton therapy is also considered to be comparatively safer in case of pediatric patients suffering from cancer. These applications are expected to drive the market for proton therapy devices in the upcoming years.

Proton Therapy Systems Market is segmented geographically into North America and Europe; which are the major markets as majority of the centers allowing proton therapy. In Asia-Pacific, the market is foretold to grow with the opening of new centers in Australia and under the effect of cumulative awareness about the welfares of this progression treatment. The high-priced cost of theory is one of the main contests to the development of this market. Proton Therapy Systems Market Key Players include IBA, Varian Technologies, Hitachi, Mitsubishi Electric, Sumitomo Heavy, ProTom International, Mevion, ProNova and Company 9.

 Get a Sample Copy of This Report @

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA


Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300


Visit Our Blog:

Leave a Reply